Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
Autor: | Nicolas Veziris, Marie Jaspard, Inés De Montgolfier, Elisabeth Elefant-Amoura, Eric Caumes, Isabelle Melonio |
---|---|
Přispěvatelé: | Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre d'Immunologie et de Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS) |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Pediatrics Epidemiology Extensively Drug-Resistant Tuberculosis Antibiotics Antitubercular Agents lcsh:Medicine chemistry.chemical_compound case study 0302 clinical medicine Pregnancy XDR TB 030212 general & internal medicine Diarylquinolines Pregnancy Complications Infectious bedaquiline bacteria ComputingMilieux_MISCELLANEOUS media_common biology multidrug-resistant tuberculosis 3. Good health Infectious Diseases tuberculosis Drug Therapy Combination Female France Microbiology (medical) Drug Adult medicine.medical_specialty Tuberculosis Georgia medicine.drug_class mycobacteria media_common.quotation_subject 030106 microbiology MDR-TB Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman linezolid lcsh:Infectious and parasitic diseases Mycobacterium tuberculosis 03 medical and health sciences respiratory infections medicine Research Letter Humans lcsh:RC109-216 antimicrobial resistance Tuberculosis Pulmonary business.industry lcsh:R Extensively drug-resistant tuberculosis medicine.disease biology.organism_classification [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology chemistry Linezolid Bedaquiline business MDR TB |
Zdroj: | Emerging Infectious Diseases Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2017, 23 (10), pp.1731-1732. ⟨10.3201/eid2310.161398⟩ Emerging Infectious Diseases, Vol 23, Iss 10, Pp 1731-1732 (2017) |
ISSN: | 1080-6059 1080-6040 |
DOI: | 10.3201/eid2310.161398⟩ |
Popis: | A woman with extremely drug-resistant tuberculosis treated with a drug regimen including linezolid and bedaquiline during her last 3 weeks of pregnancy gave birth to a child without abnormalities. No fetal toxicities were noted by 2 years after delivery. This drug combination might be safe during the late third trimester of pregnancy. |
Databáze: | OpenAIRE |
Externí odkaz: |